An aryl-hydrocarbon receptor-based drug-screening strategy for hepatocellular carcinoma based on dynamic fluorescence imaging

Chemical Communications 2026

View at publisher
Authors: Yihong Sun, Junyan Li, Weiyao Sun, Weiru Yan, Chuanchen Wu, Pengfei Shi, Shusheng Zhang
DOI: 10.1039/d5cc07101a
Cited by: 0
References: 29

Abstract

An aryl hydrocarbon receptor-specific platform, AhRPH, was devised to evaluate the therapeutic effects of liver cancer drugs. It consists of vitamin-A functionalized liposomes targeting hepatic stellate cells and encapsulating AhR-specific probes.

Fields of Study & Subjects

Molecular Sensors and Ion Detection Nanoplatforms for cancer theranostics Sulfur Compounds in Biology

Publication details

Journal / source
Chemical Communications
Volume
62
Issue
9
Pages
2967–2971
Publication date
1 January 2026
Language
EN